tiprankstipranks
Editas Medicine price target lowered to $7 from $9 at Wells Fargo
PremiumThe FlyEditas Medicine price target lowered to $7 from $9 at Wells Fargo
17d ago
Editas Medicine price target lowered to $5 from $7 at Barclays
Premium
The Fly
Editas Medicine price target lowered to $5 from $7 at Barclays
17d ago
Editas Medicine Reports Q3 2024 Results and Developments
Premium
Company Announcements
Editas Medicine Reports Q3 2024 Results and Developments
17d ago
Is EDIT a Buy, Before Earnings?
PremiumPre-EarningsIs EDIT a Buy, Before Earnings?
18d ago
Editas Medicine price target lowered to $9 from $27 at Wells Fargo
Premium
The Fly
Editas Medicine price target lowered to $9 from $27 at Wells Fargo
30d ago
Editas Medicine price target lowered to $12 from $20 at Chardan
Premium
The Fly
Editas Medicine price target lowered to $12 from $20 at Chardan
1M ago
Editas Medicine Secures $57M Deal for Gene-Editing Technology
PremiumCompany AnnouncementsEditas Medicine Secures $57M Deal for Gene-Editing Technology
2M ago
Pfizer withdrawal of Oxbryta raises questions, sends Fulcrum stock higher
Premium
The Fly
Pfizer withdrawal of Oxbryta raises questions, sends Fulcrum stock higher
2M ago
Leerink sees little impact to genetic medicines from Pfizer’s Oxbryta withdrawal
Premium
The Fly
Leerink sees little impact to genetic medicines from Pfizer’s Oxbryta withdrawal
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100